{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:50:55Z","timestamp":1794646255428,"version":"4.9.1"},"reference-count":20,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["142276"],"award-info":[{"award-number":["142276"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2023,9,27]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the regular use of xylitol, compared with sorbitol, to prevent acute otitis media (AOM), upper respiratory tract infections (URTIs) and dental caries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Blinded randomised controlled trial with a 6-month study period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Enrolment took place at 11 primary care practices in Ontario, Canada.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>Children aged 1\u20135 years who did not use xylitol or sorbitol at enrolment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Children were randomly assigned to use a placebo syrup with sorbitol or xylitol syrup two times per day for 6 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Primary outcome was the number of clinician-diagnosed AOM episodes over 6 months. Secondary outcomes were caregiver-reported URTIs and dental caries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 250 randomised children, the mean (SD) age was 38\u00b114 months and there were 124 girls (50%). There were three clinician-diagnosed AOM episodes in the 125 placebo group participants and six in the 125 xylitol group participants (OR 2.04; 95% CI 0.43, 12.92; p=0.50). There was no difference in number of caregiver-reported URTI episodes (rate ratio (RR) 0.88; 95% CI 0.70, 1.11) between the placebo (4.2 per participant over 6 months; 95% CI 3.6, 5.0) and xylitol (3.7; 95% CI 3.2, 4.4) groups. Dental caries were reported for four participants in the placebo group and two in the xylitol group (OR 0.42; 95% CI 0.04, 3.05; p=0.42). In a post-hoc analysis of URTIs during the COVID-19 pandemic, the rate among the 59 participants receiving placebo was 2.3 per participant over 6 months (95% CI 1.8, 3.0) and for the 55 receiving xylitol, 1.3 over 6 months (95% CI 0.92, 1.82; RR 0.56; 95% CI 0.36, 0.87). The most common adverse event was diarrhoea (28% with placebo; 34% with xylitol).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Regular use of xylitol did not prevent AOM, URTIs or dental caries in a trial with limited statistical power. A post-hoc analysis indicated that URTIs were less common with xylitol exposure during the COVID-19 pandemic, but this finding could be spurious.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03055091\">NCT03055091<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2023-325565","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T17:20:35Z","timestamp":1698427235000},"page":"121-124","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Xylitol for the prevention of acute otitis media episodes in children aged 1\u20135 years: a randomised controlled trial"],"prefix":"10.1136","volume":"109","clinical-trial-number":[{"clinical-trial-number":"nct03055091","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-5580","authenticated-orcid":false,"given":"Navindra","family":"Persaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Azarpazhooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Keown-Stoneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S","family":"Birken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrudee","family":"Isaranuwatchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon L","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-8631","authenticated-orcid":false,"given":"Christopher","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalah","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateenah","family":"Jaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Bazeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Laupacis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2024110504301032000_109.2.121.1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.5.563"},{"key":"2024110504301032000_109.2.121.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7066.1180"},{"key":"2024110504301032000_109.2.121.3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.4.879"},{"key":"2024110504301032000_109.2.121.4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-2373"},{"key":"2024110504301032000_109.2.121.5","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000259956.21859.dd"},{"key":"2024110504301032000_109.2.121.6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.109.2.e19","article-title":"Xylitol administered only during respiratory infections failed to prevent acute otitis media","volume":"109","author":"Tapiainen","year":"2002","journal-title":"Pediatrics"},{"key":"2024110504301032000_109.2.121.7","article-title":"Xylitol for preventing acute otitis media in children up to 12 years of age","volume":"2016","author":"Azarpazhooh","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024110504301032000_109.2.121.8","doi-asserted-by":"crossref","first-page":"100986","DOI":"10.1016\/j.eclinm.2021.100986","article-title":"Global burden of upper respiratory infections in 204 countries and territories","volume":"37","author":"Jin","year":"2021","journal-title":"eClinicalMedicine"},{"key":"2024110504301032000_109.2.121.9","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000704"},{"key":"2024110504301032000_109.2.121.10","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-77572007000200002"},{"key":"2024110504301032000_109.2.121.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"2024110504301032000_109.2.121.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020941","article-title":"Xylitol for the prevention of acute otitis media episodes in children aged 2-4 years: protocol for a pragmatic randomised controlled trial","volume":"8","author":"Persaud","year":"2018","journal-title":"BMJ Open"},{"key":"2024110504301032000_109.2.121.13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu123"},{"key":"2024110504301032000_109.2.121.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2024110504301032000_109.2.121.15","doi-asserted-by":"publisher","DOI":"10.1016\/0300-5712(91)90067-9"},{"key":"2024110504301032000_109.2.121.16","article-title":"Xylitol-containing products for preventing dental caries in children and adults","volume":"2015","author":"Riley","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024110504301032000_109.2.121.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00238-3"},{"key":"2024110504301032000_109.2.121.18","doi-asserted-by":"publisher","DOI":"10.1080\/10543409508835101"},{"key":"2024110504301032000_109.2.121.19","doi-asserted-by":"crossref","unstructured":"McCullagh P , Nelder JA . Generalized linear models. 2nd edn. Routledge, 2019. doi:10.1201\/9780203753736","DOI":"10.1201\/9780203753736"},{"key":"2024110504301032000_109.2.121.20","article-title":"Intranasal Xylitol for the treatment of COVID-19 in the outpatient setting: a pilot study","volume":"14","author":"Soler","year":"2022","journal-title":"Cureus"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-325565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:32:09Z","timestamp":1730809929000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-325565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,22]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/archdischild-2023-325565"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-325565","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]}}}